Financhill
Sell
18

CVRX Quote, Financials, Valuation and Earnings

Last price:
$6.35
Seasonality move :
41.98%
Day range:
$6.00 - $6.52
52-week range:
$4.30 - $18.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.85x
P/B ratio:
2.38x
Volume:
529.3K
Avg. volume:
640.1K
1-year change:
-21.53%
Market cap:
$165.3M
Revenue:
$51.3M
EPS (TTM):
-$2.18

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CVRX
CVRx
$14.5M -$0.49 11.94% -19.94% $11.00
IVF
INVO Fertility
$1.8M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies
$2.2M -- 157.41% -57.14% $1.45
NTRB
Nutriband
$705K -$0.13 59.2% -38.1% $13.00
NVNO
enVVeno Medical
-- -$0.30 -- -9.68% $12.50
SINT
SINTX Technologies
$751.5K -$0.70 20.07% -96.14% $30.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CVRX
CVRx
$6.34 $11.00 $165.3M -- $0.00 0% 2.85x
IVF
INVO Fertility
$1.99 -- $2.1M -- $0.00 0% 0.10x
NMTC
NeuroOne Medical Technologies
$0.67 $1.45 $20.5M -- $0.00 0% 3.30x
NTRB
Nutriband
$5.62 $13.00 $62.7M -- $0.00 0% 27.86x
NVNO
enVVeno Medical
$3.62 $12.50 $63.5M -- $0.00 0% 353.15x
SINT
SINTX Technologies
$3.16 $30.00 $7.9M -- $0.00 0% 1.97x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CVRX
CVRx
41.56% 1.790 15.48% 13.13x
IVF
INVO Fertility
-- 3.433 -- --
NMTC
NeuroOne Medical Technologies
-- -0.602 -- 2.23x
NTRB
Nutriband
1.68% 3.138 0.28% 4.65x
NVNO
enVVeno Medical
-- 0.246 -- --
SINT
SINTX Technologies
0.82% 0.321 0.68% 1.91x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CVRX
CVRx
$10.3M -$13.4M -48.31% -78.79% -99.73% -$12.9M
IVF
INVO Fertility
-- -- -- -- -- --
NMTC
NeuroOne Medical Technologies
$1.9M $1.7M -238.93% -238.93% 64.45% $183.6K
NTRB
Nutriband
$191K -$1.4M -65.19% -69.58% -210.38% -$1.1M
NVNO
enVVeno Medical
-- -$5M -- -- -- -$4M
SINT
SINTX Technologies
$38K -$1.6M -146.19% -148.9% -875.52% -$1.3M

CVRx vs. Competitors

  • Which has Higher Returns CVRX or IVF?

    INVO Fertility has a net margin of -111.48% compared to CVRx's net margin of --. CVRx's return on equity of -78.79% beat INVO Fertility's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.51% -$0.53 $118.7M
    IVF
    INVO Fertility
    -- -- --
  • What do Analysts Say About CVRX or IVF?

    CVRx has a consensus price target of $11.00, signalling upside risk potential of 73.5%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 201.51%. Given that INVO Fertility has higher upside potential than CVRx, analysts believe INVO Fertility is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 0 0
    IVF
    INVO Fertility
    0 0 0
  • Is CVRX or IVF More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.243, suggesting its more volatile than the S&P 500 by 124.267%.

  • Which is a Better Dividend Stock CVRX or IVF?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or IVF?

    CVRx quarterly revenues are $12.3M, which are larger than INVO Fertility quarterly revenues of --. CVRx's net income of -$13.8M is higher than INVO Fertility's net income of --. Notably, CVRx's price-to-earnings ratio is -- while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 2.85x versus 0.10x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    2.85x -- $12.3M -$13.8M
    IVF
    INVO Fertility
    0.10x -- -- --
  • Which has Higher Returns CVRX or NMTC?

    NeuroOne Medical Technologies has a net margin of -111.48% compared to CVRx's net margin of 54.53%. CVRx's return on equity of -78.79% beat NeuroOne Medical Technologies's return on equity of -238.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.51% -$0.53 $118.7M
    NMTC
    NeuroOne Medical Technologies
    58.85% $0.06 $2.9M
  • What do Analysts Say About CVRX or NMTC?

    CVRx has a consensus price target of $11.00, signalling upside risk potential of 73.5%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 118.05%. Given that NeuroOne Medical Technologies has higher upside potential than CVRx, analysts believe NeuroOne Medical Technologies is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 0 0
    NMTC
    NeuroOne Medical Technologies
    1 0 0
  • Is CVRX or NMTC More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.671%.

  • Which is a Better Dividend Stock CVRX or NMTC?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NMTC?

    CVRx quarterly revenues are $12.3M, which are larger than NeuroOne Medical Technologies quarterly revenues of $3.3M. CVRx's net income of -$13.8M is lower than NeuroOne Medical Technologies's net income of $1.8M. Notably, CVRx's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 2.85x versus 3.30x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    2.85x -- $12.3M -$13.8M
    NMTC
    NeuroOne Medical Technologies
    3.30x -- $3.3M $1.8M
  • Which has Higher Returns CVRX or NTRB?

    Nutriband has a net margin of -111.48% compared to CVRx's net margin of -211%. CVRx's return on equity of -78.79% beat Nutriband's return on equity of -69.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.51% -$0.53 $118.7M
    NTRB
    Nutriband
    29.58% -$0.12 $11.4M
  • What do Analysts Say About CVRX or NTRB?

    CVRx has a consensus price target of $11.00, signalling upside risk potential of 73.5%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 131.32%. Given that Nutriband has higher upside potential than CVRx, analysts believe Nutriband is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 0 0
    NTRB
    Nutriband
    1 0 0
  • Is CVRX or NTRB More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nutriband has a beta of 1.185, suggesting its more volatile than the S&P 500 by 18.545%.

  • Which is a Better Dividend Stock CVRX or NTRB?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NTRB?

    CVRx quarterly revenues are $12.3M, which are larger than Nutriband quarterly revenues of $645.8K. CVRx's net income of -$13.8M is lower than Nutriband's net income of -$1.4M. Notably, CVRx's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 2.85x versus 27.86x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    2.85x -- $12.3M -$13.8M
    NTRB
    Nutriband
    27.86x -- $645.8K -$1.4M
  • Which has Higher Returns CVRX or NVNO?

    enVVeno Medical has a net margin of -111.48% compared to CVRx's net margin of --. CVRx's return on equity of -78.79% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.51% -$0.53 $118.7M
    NVNO
    enVVeno Medical
    -- -$0.22 --
  • What do Analysts Say About CVRX or NVNO?

    CVRx has a consensus price target of $11.00, signalling upside risk potential of 73.5%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 245.3%. Given that enVVeno Medical has higher upside potential than CVRx, analysts believe enVVeno Medical is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 0 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is CVRX or NVNO More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.726%.

  • Which is a Better Dividend Stock CVRX or NVNO?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NVNO?

    CVRx quarterly revenues are $12.3M, which are larger than enVVeno Medical quarterly revenues of --. CVRx's net income of -$13.8M is lower than enVVeno Medical's net income of -$4.5M. Notably, CVRx's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 2.85x versus 353.15x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    2.85x -- $12.3M -$13.8M
    NVNO
    enVVeno Medical
    353.15x -- -- -$4.5M
  • Which has Higher Returns CVRX or SINT?

    SINTX Technologies has a net margin of -111.48% compared to CVRx's net margin of -882.81%. CVRx's return on equity of -78.79% beat SINTX Technologies's return on equity of -148.9%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.51% -$0.53 $118.7M
    SINT
    SINTX Technologies
    19.79% -$1.26 $3.9M
  • What do Analysts Say About CVRX or SINT?

    CVRx has a consensus price target of $11.00, signalling upside risk potential of 73.5%. On the other hand SINTX Technologies has an analysts' consensus of $30.00 which suggests that it could grow by 849.37%. Given that SINTX Technologies has higher upside potential than CVRx, analysts believe SINTX Technologies is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 0 0
    SINT
    SINTX Technologies
    1 1 0
  • Is CVRX or SINT More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.821, suggesting its less volatile than the S&P 500 by 17.937%.

  • Which is a Better Dividend Stock CVRX or SINT?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or SINT?

    CVRx quarterly revenues are $12.3M, which are larger than SINTX Technologies quarterly revenues of $192K. CVRx's net income of -$13.8M is lower than SINTX Technologies's net income of -$1.7M. Notably, CVRx's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 2.85x versus 1.97x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    2.85x -- $12.3M -$13.8M
    SINT
    SINTX Technologies
    1.97x -- $192K -$1.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

How to Change Your Stock Portfolio During a Bear Market
How to Change Your Stock Portfolio During a Bear Market

The standard definition of a bear market is that one…

Why Is Newegg Commerce Up So Much?
Why Is Newegg Commerce Up So Much?

Consumer electronics eCommerce store Newegg (NASDAQ:NEGG) has staged a dramatic…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
81
SMLR alert for May 17

Semler Scientific [SMLR] is up 28.56% over the past day.

Sell
25
GLOB alert for May 17

Globant SA [GLOB] is down 23.54% over the past day.

Buy
94
HIMS alert for May 17

Hims & Hers Health [HIMS] is up 10.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock